Kenneth W. Duncan,Richard Chesworth,Michael John Munchhof
申请号:
US14136559
公开号:
US09365555B2
申请日:
2013.12.20
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.